Impact of sustained deprenyl (selegiline) in levodopa-treated Parkinson's disease: A randomized placebo-controlled extension of the deprenyl and tocopherol antioxidative therapy of parkinsonism trial-Reference-Cited by-同舟云学术

Impact of sustained deprenyl (selegiline) in levodopa-treated Parkinson's disease: A randomized placebo-controlled extension of the deprenyl and tocopherol antioxidative therapy of parkinsonism trial

Published:2002-04-30 Issue:5 Volume:51 Page:604-612
ISSN:0364-5134
Container-title:Annals of Neurology
language:en
Short-container-title:Ann Neurol.

Author:

Shoulson Ira,Oakes David,Fahn Stanley,Lang Anthony,Langston J. William,LeWitt Peter,Olanow C. Warren,Penney John B.,Tanner Caroline,Kieburtz Karl,Rudolph Alice,

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Reference23 articles.

1. Effect of Deprenyl on the Progression of Disability in Early Parkinson's Disease

2. Effects of Tocopherol and Deprenyl on the Progression of Disability in Early Parkinson's Disease

3. DATATOP: A decade of neuroprotective inquiry

4. Impact of deprenyl and tocopherol treatment on Parkinson's disease in DATATOP subjects not requiring levodopa

5. Impact of deprenyl and tocopherol treatment on Parkinson's disease in DATATOP patients requiring levodopa

Cited by 233 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacotherapy of motor symptoms in early and mid-stage Parkinson’s disease: guideline “Parkinson’s disease” of the German Society of Neurology;Journal of Neurology;2024-08-29

2. Free-water diffusion magnetic resonance imaging under selegiline treatment in Parkinson's disease;Journal of the Neurological Sciences;2024-02

3. Non-steroidal anti-inflammatory drug use and markers of Parkinson's disease progression: A retrospective cohort study;Journal of the Neurological Sciences;2023-11

4. Safety review of current pharmacotherapies for levodopa-treated patients with Parkinson’s disease;Expert Opinion on Drug Safety;2023-07-03

5. Levodopa-Induced Dyskinesias in Parkinson’s Disease: An Overview on Pathophysiology, Clinical Manifestations, Therapy Management Strategies and Future Directions;Journal of Clinical Medicine;2023-06-30